Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$38.20 USD
-0.95 (-2.43%)
Updated Sep 29, 2023 04:00 PM ET
After-Market: $38.21 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum B VGM
Detailed Estimates
Estimates
Exp Earnings Date | 11/14/23 |
---|---|
Current Quarter | 0.74 |
EPS Last Quarter | 0.74 |
Last EPS Surprise | 17.46% |
ABR | 1.70 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.66 |
Next Year | 3.79 |
EPS (TTM) | 2.43 |
P/E (F1) | 14.36 |
Sales Estimates
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 228.49M | 228.68M | 840.35M | 1.09B |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 240.58M | 233.34M | 845.38M | 1.21B |
Low Estimate | 223.28M | 221.61M | 832.22M | 990.86M |
Year ago Sales | 208.98M | 181.50M | 660.12M | 840.35M |
Year over Year Growth Est. | 9.33% | 26.00% | 27.30% | 29.39% |
Earnings Estimates
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.74 | 0.72 | 2.66 | 3.79 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | 0.72 | 0.73 | 2.66 | 3.54 |
High Estimate | 0.78 | 0.76 | 2.68 | 4.58 |
Low Estimate | 0.71 | 0.70 | 2.65 | 3.01 |
Year ago EPS | 0.74 | 0.48 | 2.21 | 2.66 |
Year over Year Growth Est. | 0.00% | 50.00% | 20.36% | 42.48% |
Agreement - Estimate Revisions
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 3 | 1 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 3 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Current | 0.74 | 0.72 | 2.66 | 3.79 |
7 Days Ago | 0.74 | 0.72 | 2.66 | 3.79 |
30 Days Ago | 0.75 | 0.74 | 2.67 | 3.75 |
60 Days Ago | 0.73 | 0.77 | 2.59 | 3.73 |
90 Days Ago | 0.73 | 0.77 | 2.59 | 3.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2023) |
Next Qtr (12/2023) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.74 | 0.72 | 2.66 | 3.54 |
Zacks Consensus Estimate | 0.74 | 0.72 | 2.66 | 3.79 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -6.60% |
Surprise - Reported Earnings History
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Quarter Ending (12/2022) |
Quarter Ending (9/2022) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.74 | 0.47 | 0.48 | 0.74 | NA |
Estimate | 0.63 | 0.48 | 0.47 | 0.52 | NA |
Difference | 0.11 | -0.01 | 0.01 | 0.22 | 0.08 |
Surprise | 17.46% | -2.08% | 2.13% | 42.31% | 14.96% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more